Abstract
Oral Realgar-Indigo Naturalis Formula Versus Intravenous Arsenic Trioxide for Non-High-Risk Patients with Acute Promyelocytic Leukemia: Interim Results of a Multicenter Randomized Controlled Trial APL16
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have